Free Trial

Rockwell Medical (RMTI) Competitors

Rockwell Medical logo
$1.18 -0.02 (-1.26%)
As of 12:05 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

RMTI vs. ABT, ISRG, BSX, SYK, MDT, BDX, IDXX, EW, RMD, and DXCM

Should you be buying Rockwell Medical stock or one of its competitors? The main competitors of Rockwell Medical include Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Boston Scientific (BSX), Stryker (SYK), Medtronic (MDT), Becton, Dickinson and Company (BDX), IDEXX Laboratories (IDXX), Edwards Lifesciences (EW), ResMed (RMD), and DexCom (DXCM). These companies are all part of the "health care equipment" industry.

Rockwell Medical vs. Its Competitors

Rockwell Medical (NASDAQ:RMTI) and Abbott Laboratories (NYSE:ABT) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends.

Abbott Laboratories has a net margin of 31.88% compared to Rockwell Medical's net margin of -2.38%. Abbott Laboratories' return on equity of 17.78% beat Rockwell Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Rockwell Medical-2.38% -6.79% -3.77%
Abbott Laboratories 31.88%17.78%10.64%

Rockwell Medical has a beta of 1.73, indicating that its share price is 73% more volatile than the S&P 500. Comparatively, Abbott Laboratories has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500.

In the previous week, Abbott Laboratories had 139 more articles in the media than Rockwell Medical. MarketBeat recorded 142 mentions for Abbott Laboratories and 3 mentions for Rockwell Medical. Abbott Laboratories' average media sentiment score of 0.85 beat Rockwell Medical's score of 0.00 indicating that Abbott Laboratories is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Rockwell Medical
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Abbott Laboratories
64 Very Positive mention(s)
11 Positive mention(s)
25 Neutral mention(s)
6 Negative mention(s)
0 Very Negative mention(s)
Positive

Abbott Laboratories has higher revenue and earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Abbott Laboratories, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Rockwell Medical$87.97M0.46-$480K-$0.06-19.58
Abbott Laboratories$43.11B5.17$13.40B$7.9816.06

Rockwell Medical currently has a consensus price target of $4.00, suggesting a potential upside of 240.43%. Abbott Laboratories has a consensus price target of $147.00, suggesting a potential upside of 14.70%. Given Rockwell Medical's higher possible upside, research analysts clearly believe Rockwell Medical is more favorable than Abbott Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Rockwell Medical
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.75
Abbott Laboratories
0 Sell rating(s)
4 Hold rating(s)
17 Buy rating(s)
2 Strong Buy rating(s)
2.91

23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 75.2% of Abbott Laboratories shares are owned by institutional investors. 3.6% of Rockwell Medical shares are owned by insiders. Comparatively, 0.5% of Abbott Laboratories shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Abbott Laboratories beats Rockwell Medical on 14 of the 17 factors compared between the two stocks.

Get Rockwell Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for RMTI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RMTI vs. The Competition

MetricRockwell MedicalMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$40.46M$10.67B$6.16B$10.63B
Dividend YieldN/A1.88%5.72%4.85%
P/E Ratio-19.5820.8529.4927.39
Price / Sales0.4632.85494.36189.83
Price / Cash9.2525.1225.8230.35
Price / Book1.163.5112.466.70
Net Income-$480K$208.83M$3.32B$276.34M
7 Day Performance-2.08%0.79%2.21%0.29%
1 Month Performance-11.65%1.16%9.00%4.13%
1 Year Performance-66.19%-7.55%63.72%33.94%

Rockwell Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RMTI
Rockwell Medical
3.791 of 5 stars
$1.18
-1.3%
$4.00
+240.4%
-65.6%$40.46M$87.97M-19.58300News Coverage
ABT
Abbott Laboratories
4.9673 of 5 stars
$131.52
-0.8%
$146.17
+11.1%
+8.5%$230.73B$41.95B16.48114,000Earnings Report
Analyst Forecast
Analyst Revision
ISRG
Intuitive Surgical
4.7997 of 5 stars
$435.73
+1.4%
$584.76
+34.2%
-12.0%$154.00B$8.35B60.7715,638Analyst Downgrade
Short Interest ↑
BSX
Boston Scientific
4.6959 of 5 stars
$94.92
-0.5%
$120.71
+27.2%
+14.2%$141.37B$16.75B56.5053,000Upcoming Earnings
SYK
Stryker
4.7699 of 5 stars
$364.95
+0.1%
$432.14
+18.4%
+3.2%$139.39B$22.60B48.3453,000Positive News
Analyst Upgrade
MDT
Medtronic
4.9304 of 5 stars
$95.63
+0.2%
$102.41
+7.1%
+4.0%$122.43B$33.54B26.3495,000Positive News
BDX
Becton, Dickinson and Company
4.9169 of 5 stars
$186.76
+0.1%
$205.40
+10.0%
-21.5%$53.47B$20.18B33.5974,000Positive News
IDXX
IDEXX Laboratories
4.2727 of 5 stars
$633.32
+2.8%
$656.50
+3.7%
+40.6%$49.29B$3.90B52.7311,000Positive News
EW
Edwards Lifesciences
4.6347 of 5 stars
$72.94
-1.4%
$87.06
+19.4%
+7.2%$43.41B$5.44B10.4915,800Options Volume
RMD
ResMed
4.6867 of 5 stars
$273.10
+0.4%
$292.91
+7.3%
+13.1%$39.70B$5.15B28.7210,600Positive News
Analyst Forecast
Analyst Revision
DXCM
DexCom
4.8941 of 5 stars
$65.20
+0.1%
$97.42
+49.4%
-5.5%$25.54B$4.03B45.2810,300Analyst Forecast

Related Companies and Tools


This page (NASDAQ:RMTI) was last updated on 10/21/2025 by MarketBeat.com Staff
From Our Partners